Donor lymphocytes depleted of alloreactive T-cells (ATIR101) improve overall survival and reduce transplant related mortality in a T-cell depleted haploidentical HSCT: Results from a Phase 2 trial in patients with AML and ALL Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Roy, D-C
  • Lachance, S
  • Roy, J
  • Walker, I
  • Maertens, J
  • Cohen, S
  • Foley, Ronan
  • Lewalle, P
  • Olavarria, E
  • Selleslag, D
  • Ruediger, M
  • Velthuis, J
  • Reitsma, K
  • Gerez, L
  • Rovers, J
  • Boenig, H
  • Mielke, S

publication date

  • March 1, 2016